Undergoing EMT usually empowers non- or low-metastatic tumor cells to be highly aggressive, and lost expression of epithelial markers such as E-cadherin and increased expression of mesenchymal markers such as Vimentin can be detected in, at least a subset of metastatic tumor tissues7. This evidence concerns the gene CDH1 and neoplasm.